Aradigm

aradigmhealth.com

Aradigm was founded to solve one of healthcare’s most urgent and complex challenges: ensuring sustainable access to the next generation of transformative therapies—cell and gene therapies (CGTs). Treatments are now available that can prevent or cure diseases that have historically caused enormous suffering and mortality, by targeting the genetic or cellular causes of the disease. However, as treatments become increasingly transformative—and costly—traditional systems for payment and delivery haven’t kept pace. We built Aradigm as a public benefit corporation to foster sustainable access to transformative therapies with an entirely pass-through business model. We partner with employers, payers, providers, and manufacturers to deliver a novel, trustworthy, and comprehensive model—essential to shift the paradigm in delivering breakthrough therapies.